Abbott, CamDiab and Ypsomed Unveil New Automated Insulin Delivery Partnership for People with DiabetesPRNewsWire • 04/27/22
Abbott Recommends Rejection of Below-Market Mini-Tender Offer by TRC Capital Investment CorporationPRNewsWire • 04/26/22
Here's the Worst News for Abbott Right Now (and Why Investors Shouldn't Worry)The Motley Fool • 04/26/22
Abbott Strengthens Its Connected Care Technologies with Latest NeuroSphere™ myPath™ Digital Health AppPRNewsWire • 04/25/22
Abbott Labs First-Quarter Results Top Estimates, Earnings Outlook ShortInvestors Business Daily • 04/20/22
Abbott predicts fewer sales of COVID-19 tests in 2022 but says the business of at-home tests isn't going awayMarket Watch • 04/20/22
Abbott Laboratories (ABT) CEO Robert Ford on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/20/22